These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37240076)

  • 1. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
    Hsu PL; Hsu SM
    Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
    Ganapathi KA; Nicolae A; Egan C; Geng H; Xi L; Pack SD; McFadden JR; Raffeld M; Jaffe ES; Pittaluga S
    Br J Haematol; 2024 May; 204(5):1862-1871. PubMed ID: 38613165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.
    Nakashima M; Yamochi T; Watanabe M; Uchimaru K; Utsunomiya A; Higashihara M; Watanabe T; Horie R
    Clin Cancer Res; 2018 Nov; 24(21):5445-5457. PubMed ID: 30068708
    [No Abstract]   [Full Text] [Related]  

  • 5. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
    Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
    Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
    Maeda N; Muta H; Oflazoglu E; Yoshikai Y
    Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.
    Nakashima M; Utsunomiya A; Watanabe T; Horie R; Uchimaru K
    Cancer Sci; 2023 Apr; 114(4):1556-1568. PubMed ID: 36541483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression.
    Ohtsuka E; Kikuchi H; Nasu M; Takita-Sonoda Y; Fujii H; Yokoyama S
    Leuk Lymphoma; 1994 Oct; 15(3-4):303-10. PubMed ID: 7866279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.
    Gualco G; Chioato L; Weiss LM; Harrington WJ; Bacchi CE
    Am J Clin Pathol; 2009 Jul; 132(1):28-33. PubMed ID: 19864230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.
    Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE
    Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1.
    Hori M; Mitsuhashi S; Kobayashi T; Nagasawa T; Mori N; Miwa M; Abe T
    Br J Haematol; 1994 Oct; 88(2):419-20. PubMed ID: 7803296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
    Rinaldi I
    Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area.
    Takeshita M; Ohshima K; Akamatsu M; Ohgami A; Kikuchi M; Suzumiya J; Uike N; Okamura T; Nakayama J
    Hum Pathol; 1995 Jun; 26(6):614-9. PubMed ID: 7774890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
    Ramos CA; Ballard B; Zhang H; Dakhova O; Gee AP; Mei Z; Bilgi M; Wu MF; Liu H; Grilley B; Bollard CM; Chang BH; Rooney CM; Brenner MK; Heslop HE; Dotti G; Savoldo B
    J Clin Invest; 2017 Sep; 127(9):3462-3471. PubMed ID: 28805662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.